Norbert Lehming

1.7k total citations
40 papers, 1.4k citations indexed

About

Norbert Lehming is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Norbert Lehming has authored 40 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 8 papers in Genetics and 7 papers in Oncology. Recurrent topics in Norbert Lehming's work include Genomics and Chromatin Dynamics (12 papers), Ubiquitin and proteasome pathways (11 papers) and Fungal and yeast genetics research (10 papers). Norbert Lehming is often cited by papers focused on Genomics and Chromatin Dynamics (12 papers), Ubiquitin and proteasome pathways (11 papers) and Fungal and yeast genetics research (10 papers). Norbert Lehming collaborates with scholars based in Singapore, Germany and Israel. Norbert Lehming's co-authors include Mark Ptashne, B. von Wilcken‐Bergmann, Benno Müller‐Hill, Joshua M. Brickman, J. Sartorius, Jutta Schüller, Agnès Le Saux, T Maniatis, Dimitris Thanos and Jun Ma and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The EMBO Journal.

In The Last Decade

Norbert Lehming

40 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Norbert Lehming Singapore 19 1.2k 320 149 113 98 40 1.4k
Omar Wagih United Kingdom 14 1.1k 1.0× 211 0.7× 92 0.6× 137 1.2× 70 0.7× 17 1.4k
S S Sommer United States 10 1.3k 1.1× 309 1.0× 101 0.7× 125 1.1× 120 1.2× 11 1.7k
Gregory A. Wasney Canada 23 1.4k 1.1× 240 0.8× 106 0.7× 70 0.6× 156 1.6× 29 1.9k
Phil Hieter Canada 11 1.6k 1.4× 204 0.6× 146 1.0× 234 2.1× 75 0.8× 14 2.0k
Nora Cronin United Kingdom 18 983 0.8× 210 0.7× 126 0.8× 62 0.5× 145 1.5× 29 1.3k
Assen Marintchev United States 27 2.0k 1.7× 181 0.6× 94 0.6× 125 1.1× 199 2.0× 41 2.2k
William H. Eschenfeldt United States 20 1.0k 0.9× 236 0.7× 123 0.8× 121 1.1× 92 0.9× 27 1.4k
Hartmut Voss Germany 22 1.2k 1.0× 315 1.0× 133 0.9× 198 1.8× 181 1.8× 53 1.7k
Kai-Fa Huang Taiwan 21 689 0.6× 338 1.1× 107 0.7× 51 0.5× 93 0.9× 56 1.1k
Felipe Trajtenberg Uruguay 18 788 0.7× 308 1.0× 168 1.1× 97 0.9× 53 0.5× 29 1.1k

Countries citing papers authored by Norbert Lehming

Since Specialization
Citations

This map shows the geographic impact of Norbert Lehming's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norbert Lehming with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norbert Lehming more than expected).

Fields of papers citing papers by Norbert Lehming

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norbert Lehming. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norbert Lehming. The network helps show where Norbert Lehming may publish in the future.

Co-authorship network of co-authors of Norbert Lehming

This figure shows the co-authorship network connecting the top 25 collaborators of Norbert Lehming. A scholar is included among the top collaborators of Norbert Lehming based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norbert Lehming. Norbert Lehming is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Seah, Geok Leng, et al.. (2025). Mitochondria and the Repurposing of Diabetes Drugs for Off-Label Health Benefits. International Journal of Molecular Sciences. 26(1). 364–364. 10 indexed citations
2.
Lichtenstein, Michal, et al.. (2023). Systematic Approaches to Study Eclipsed Targeting of Proteins Uncover a New Family of Mitochondrial Proteins. Cells. 12(11). 1550–1550. 3 indexed citations
3.
Wang, Suqing, Teck Kwang Lim, Qingsong Lin, et al.. (2021). Fumarase affects the deoxyribonucleic acid damage response by protecting the mitochondrial desulfurase Nfs1p from modification and inactivation. iScience. 24(11). 103354–103354. 6 indexed citations
4.
Lisby, Michael, et al.. (2017). Fumarase is involved in DNA double-strand break resection through a functional interaction with Sae2. Current Genetics. 64(3). 697–712. 23 indexed citations
5.
Naamati, Adi, et al.. (2016). Human Fumarate Hydratase Is Dual Localized by an Alternative Transcription Initiation Mechanism. Traffic. 17(7). 720–732. 29 indexed citations
6.
Lehming, Norbert, et al.. (2012). How the ubiquitin proteasome system regulates the regulators of transcription. Transcription. 3(5). 235–239. 8 indexed citations
7.
Lehming, Norbert, et al.. (2011). Molecular analysis of Plasmodium falciparum co-chaperone Aha1 supports its interaction with and regulation of Hsp90 in the malaria parasite. The International Journal of Biochemistry & Cell Biology. 44(1). 233–245. 10 indexed citations
8.
Lehming, Norbert, et al.. (2009). Degradation-resistant protein domains limit host cell processing and immune detection of mycobacteria. Molecular Immunology. 46(7). 1312–1318. 28 indexed citations
9.
Xue, Xiaowei & Norbert Lehming. (2008). Nhp6p and Med3p Regulate Gene Expression by Controlling the Local Subunit Composition of RNA Polymerase II. Journal of Molecular Biology. 379(2). 212–230. 7 indexed citations
10.
Saux, Agnès Le, et al.. (2007). Gal11p Dosage-compensates Transcriptional Activator Deletions via Taf14p. Journal of Molecular Biology. 374(1). 9–23. 18 indexed citations
11.
Schüller, Jutta & Norbert Lehming. (2003). The Cyclin in the RNA Polymerase Holoenzyme Is a Target for the Transcriptional Repressor Tup1p in <i>Saccharomyces cerevisiae</i>. Microbial Physiology. 5(4). 199–205. 10 indexed citations
12.
Lehming, Norbert. (2002). Analysis of protein-protein proximities using the split-ubiquitin system. Briefings in Functional Genomics and Proteomics. 1(3). 230–238. 21 indexed citations
13.
Lehming, Norbert, et al.. (2001). Why Ppr1p is a weak activator of transcription. FEBS Letters. 494(1-2). 64–68. 5 indexed citations
14.
Lehming, Norbert, et al.. (2000). Srb7p is essential for the activation of a subset of genes. FEBS Letters. 484(1). 48–54. 13 indexed citations
15.
Lehming, Norbert, et al.. (1999). Analysis of the in vivo interaction between a basic repressor and an acidic activator. FEBS Letters. 453(3). 299–304. 14 indexed citations
16.
Lehming, Norbert, Dimitris Thanos, Joshua M. Brickman, et al.. (1994). An HMG-like protein that can switch a transcriptional activator to a repressor. Nature. 371(6493). 175–179. 201 indexed citations
17.
Saha, Shamol, Joshua M. Brickman, Norbert Lehming, & Mark Ptashne. (1993). New eukaryotic transcriptional repressers. Nature. 363(6430). 648–652. 81 indexed citations
18.
Lehming, Norbert, et al.. (1991). The roles of residues 5 and 9 of the recognition helix of Lac repressor in lac operator binding. Journal of Molecular Biology. 218(2). 313–321. 27 indexed citations
19.
Kisters–Woike, Brigitte, et al.. (1991). A model of the lac repressor–operator complex based on physical and genetic data. European Journal of Biochemistry. 198(2). 411–419. 24 indexed citations
20.
Cubellis, Maria Vittoria, Maria G. Masucci, Niels Behrendt, et al.. (1990). Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis. The EMBO Journal. 9(5). 1674–1674. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026